UBS Maintains Buy on CareTrust REIT, Raises Price Target to $43

Benzinga · 3d ago
UBS analyst Michael Goldsmith maintains CareTrust REIT (NYSE:CTRE) with a Buy and raises the price target from $42 to $43.